Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00374764
Status:
COMPLETED
Last Update Posted:
2007-02-16
First Post:
2006-09-07
Brief Title:
Comparison of Applied Behavioral Analysis ABA Versus ABA and Risperidone
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone
Status:
COMPLETED
Status Verified Date:
2002-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypotheses
1 Preschool children with autism spectrum disorders ASDs who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment
2 Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone
3 Young age cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment
4 At baseline children with ASDs will show significantly lower performances on measures of cognitive neuropsychological and socio-emotional functioning than age-matched typically developing controls
1 Preschool children with autism spectrum disorders ASDs who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment
2 Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone
3 Young age cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment
4 At baseline children with ASDs will show significantly lower performances on measures of cognitive neuropsychological and socio-emotional functioning than age-matched typically developing controls
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None